title: New strategies for CNS injury and repair using stem cells, nanomedicine, neurotrophic factors and novel neuroprotective agents.
abstract: The 8th Annual Conference of the Global College of Neuroprotection and Neuroregeneration (GCNN) was global in the true sense of the word as it was held beyond European boundaries for the first time in the beautiful ambience of the ancient and modern environment of the Hashemite Kingdom of Jordan on 27-30 April 2011. The meeting was organized together with the 4th International Association of Neurorestoratology (IANR; Beijing, China) and the 11th meeting of the American Society for Neural Therapy and Repair (ASNTR; FL, USA). The first joint meeting was extremely successful and attracted more than 600 delegates including top experts, research students and educators from industry, academia, research organizations, universities and medical representatives from across the globe. The focal theme of this meeting was 'Exploring new strategies for neuroregenerative therapy for CNS injury and repair'. The Jordanian Association of Orthopedic Surgeons chaired by Ziad Al Zoubi served as the local host. HRH Princess Basma Bint Talal of Jordan inaugurated the congress. The salient new discoveries and recommendations for future strategies discussed during the meeting are summarized in this article.
authors.affiliation: Laboratory of Cerebrovascular Research, Department of Surgical Sciences, Anesthesiology & Intensive Care Medicine, University Hospital, Uppsala University, SE-75185 Uppsala, Sweden. sharma@surgsci.uu.se
authors.forename: Hari Shanker
authors.initials: HS
authors.lastname: Sharma
authors.forename: Aruna
authors.initials: A
authors.lastname: Sharma
mesh_terms: D001930:Brain Injuries / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D002490:Central Nervous System / Q000293:injuries / Q000473:pathology; D002493:Central Nervous System Diseases / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D050997:Nanomedicine / Q000379:methods*; D009414:Nerve Growth Factors / Q000627:therapeutic use*; D009416:Nerve Regeneration / Q000187:drug effects; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D033581:Stem Cell Transplantation; D020196:Trauma, Nervous System / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*
chemical_list: D009414:Nerve Growth Factors; D018696:Neuroprotective Agents